Metamodeling Techniques Applied to the Design of Reconfigurable Control Applications

In order to realize autonomous manufacturing systems in environments characterized by high dynamics and high complexity of task, it is necessary to improve the control system modelling and performance. This requires the use of better and reusable abstractions. In this paper, we explore the metamodel techniques as a foundation to the solution of this problem. The increasing popularity of model-driven approaches and a new generation of tools to support metamodel techniques are changing software engineering landscape, boosting the adoption of new methodologies for control application development

A highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (PRRSV-1) strongly modulates cellular innate and adaptive immune subsets upon experimental infection

Highly pathogenic (HP) PRRSV isolates have been discovered within both PRRSV-1 and PRRSV-2 genotypes and investigated in recent years especially for their ability to cause extremely severe disease in conventional pig herds. The exacerbation of general and respiratory clinical signs has been attributed not only to an efficient replication (virulence) but also to the ability to dysregulate viral recognition and induce mechanisms of immune evasion or immune enhancement of humoral and cellular anti-viral responses differently from non-HP PRRSV isolates in terms of intensity and temporal onset. Thus, the understanding of the immunopathogenesis of HP PRRSV is a major concern for the study of virus biology and development of efficacious vaccines. The present study aims at addressing the modulation of relevant immune cell subsets by flow cytometry in the blood of 4- week-old pigs experimentally infected with the recently discovered PR40/2014 HP PRRSV-1.1 strain phenotypically characterized in Canelli et al. (2017) compared to pigs infected with a non-HP PRRSV isolate (PR11/ 2014) and uninfected controls. PR40 infected animals showed an early and marked reduction of pro-inflammatory CD172α+ CD14+CD16+ and CD14+CD163+ monocytes and TCRγδ+CD8α+/CD8α- lymphocytes when pigs were most infected, possibly due to a recruitment sustaining an acute inflammatory response in target tissues. The prolonged increased CD3+CD16+ NKT cell levels may sustain peripheral inflammation and/ or the anti-viral response. The late reduction (potential depletion) of γ/δ T lymphocytes and CD3+CD4+CD8α- naïve Th lymphocytes paralleled with the delayed increase of CD3+CD4+CD8α+ memory and CD3+CD4- CD8α/β+cytotoxic T lymphocytes. In addition, PR40 infection showed an early depletion of activated CD4+CD25+ T lymphocytes and Tregs together with an intense and lasting depletion of CD21+ B lymphocytes. Overall, these features demonstrate that the more severe clinical signs observed upon infection with the HP PR40 strain are sustained by remarkable changes in the peripheral blood distribution of immune cells and provide further insights into the immune regulation/immunopathogenesis induced by PRRSV-1 subtype 1 European isolates

A novel framework for chimeric transcript detection based on accurate gene fusion model

Next generation sequencing plays a key role in the detection of structural variations. Chimeric transcripts are relevant examples of such variations, as they are involved in several diseases. In this work, we propose an effective methodology for the detection of fused transcripts in RNA-Seq paired-end data. The proposed methodology is based on an accurate fusion model implemented by a set of filters reducing the impact of artifacts. Moreover, the methodology accounts for transcripts consistently expressing in the sample under study even if they are not annotated. The effectiveness of the proposed solution has been experimentally validated on of Chronic Myelogenous Leukemia (CML) samples, providing both the genes involved in the fusion and the exact chimeric sequence. \ua9 2011 IEEE

Energy Performance Assessment of Innovative Building Solutions Coming from Construction and Demolition Waste Materials

Prefabricated solutions incorporating thermal insulation are increasingly adopted as an energy conservation measure for building renovation. The InnoWEE European project developed three technologies from Construction and Demolition Waste (CDW) materials through a manufacturing process that supports the circular economy strategy of the European Union. Two of them consisted of geopolymer panels incorporated into an External Thermal Insulation Composite System (ETICS) and a ventilated façade. This study evaluates their thermal performance by means of monitoring data from three pilot case studies in Greece, Italy, and Romania, and calibrated building simulation models enabling the reliable prediction of energy savings in different climates and use scenarios. Results showed a reduction in energy demand for all demo buildings, with annual energy savings up to 25% after placing the novel insulation solutions. However, savings are highly dependent on weather conditions since the panels affect cooling and heating loads differently. Finally, a parametric assessment is performed to assess the impact of insulation thickness through an energy performance prediction and a cash flow analysis.This research was funded by the European Union’s Horizon 2020 research and innovation program under grant agreement No. 723916 (Project H2020-EEB-2016 InnoWEE, G.A. 723916). This study reflects only the authors’ views and the Commission is not responsible for any use that may be made of the information contained therei

Klebsiella pneumoniae carrying multiple alleles of antigen 43-encoding gene of Escherichia coli associated with biofilm formation

A clinical strain of Klebsiella pneumoniae typed as sequence type 307 carrying three different alleles of the flu gene encoding the Escherichia coli virulence factor antigen 43 associated with biofilm formation was detected and characterized. The flu alleles are located in the chromosome inside putative integrative conjugative elements. The strain displays the phenotypes associated with Ag43, i.e. bi-phasic colony morphology and enhanced biofilm production. Furthermore, the strain produces low amount of capsule known to affect Ag43 function. Analysis of 1431 worldwide deposited genomes revealed that 3.7% Klebsiella pneumoniae carry one or two flu alleles

Impact of maternally derived immunity on piglets’ immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age

BACKGROUND: This study was aimed at evaluating the clinical protection, the level of Porcine circovirus type 2 (PCV2) viremia and the immune response (antibodies and IFN-γ secreting cells (SC)) in piglets derived from PCV2 vaccinated sows and themselves vaccinated against PCV2 at different age, namely at 4, 6 and 8 weeks. The cohort study has been carried out over three subsequent production cycles (replicates). At the start/enrolment, 46 gilts were considered at first mating, bled and vaccinated. At the first, second and third farrowing, dams were bled and re-vaccinated at the subsequent mating after weaning piglets. Overall 400 piglets at each farrowing (first, second and third) were randomly allocated in three different groups (100 piglets/group) based on the timing of vaccination (4, 6 or 8 weeks of age). A fourth group was kept non-vaccinated (controls). Piglets were vaccinated intramuscularly with one dose (2 mL) of a commercial PCV2a-based subunit vaccine (Porcilis® PCV). Twenty animals per group were bled at weaning and from vaccination to slaughter every 4 weeks for the detection of PCV2 viremia, humoral and cell-mediated immune responses. Clinical signs and individual treatments (morbidity), mortality, and body weight of all piglets were recorded. RESULTS: All vaccination schemes (4, 6 and 8 weeks of age) were able to induce an antibody response and IFN-γ SC. The highest clinical and virological protection sustained by immune reactivity was observed in pigs vaccinated at 6 weeks of age. Overall, repeated PCV2 vaccination in sows at mating and the subsequent higher levels of maternally derived antibodies did not significantly interfere with the induction of both humoral and cell-mediated immunity in their piglets after vaccination. CONCLUSIONS: The combination of vaccination in sows at mating and in piglets at 6 weeks of age was more effective for controlling PCV2 natural infection, than other vaccination schemas, thus sustaining that some interference of MDA with the induction of an efficient immune response could be considered. In conclusion, optimal vaccination strategy needs to balance the levels of passive immunity, the management practices and timing of infection

Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality

none28noThe stratification of mortality risk in COVID-19 patients remains extremely challenging for physicians, especially in older patients. Innovative minimally invasive molecular biomarkers are needed to improve the prediction of mortality risk and better customize patient management. In this study, aimed at identifying circulating miRNAs associated with the risk of COVID-19 in-hospital mortality, we analyzed serum samples of 12 COVID-19 patients by small RNA-seq and validated the findings in an independent cohort of 116 COVID-19 patients by qRT-PCR. Thirty-four significantly deregulated miRNAs, 25 downregulated and 9 upregulated in deceased COVID-19 patients compared to survivors, were identified in the discovery cohort. Based on the highest fold-changes and on the highest expression levels, 5 of these 34 miRNAs were selected for the analysis in the validation cohort. MiR-320b and miR-483-5p were confirmed to be significantly hyper-expressed in deceased patients compared to survived ones. Kaplan-Meier and Cox regression models, adjusted for relevant confounders, confirmed that patients with the 20% highest miR-320b and miR-483-5p serum levels had three-fold increased risk to die during in-hospital stay for COVID-19. In conclusion, high levels of circulating miR-320b and miR-483-5p can be useful as minimally invasive biomarkers to stratify older COVID-19 patients with an increased risk of in-hospital mortality.restrictedGiuliani, Angelica; Matacchione, Giulia; Ramini, Deborah; Di Rosa, Mirko; Bonfigli, Anna Rita; Sabbatinelli, Jacopo; Monsurrò, Vladia; Recchioni, Rina; Marcheselli, Fiorella; Marchegiani, Francesca; Piacenza, Francesco; Cardelli, Maurizio; Galeazzi, Roberta; Pomponio, Giovanni; Ferrarini, Alessia; Gabrielli, Armando; Baroni, Silvia Svegliati; Moretti, Marco; Sarzani, Riccardo; Giordano, Piero; Cherubini, Antonio; Corsonello, Andrea; Antonicelli, Roberto; Procopio, Antonio Domenico; Ferracin, Manuela; Bonafè, Massimiliano; Lattanzio, Fabrizia; Olivieri, FabiolaGiuliani, Angelica; Matacchione, Giulia; Ramini, Deborah; Di Rosa, Mirko; Bonfigli, Anna Rita; Sabbatinelli, Jacopo; Monsurrò, Vladia; Recchioni, Rina; Marcheselli, Fiorella; Marchegiani, Francesca; Piacenza, Francesco; Cardelli, Maurizio; Galeazzi, Roberta; Pomponio, Giovanni; Ferrarini, Alessia; Gabrielli, Armando; Baroni, Silvia Svegliati; Moretti, Marco; Sarzani, Riccardo; Giordano, Piero; Cherubini, Antonio; Corsonello, Andrea; Antonicelli, Roberto; Procopio, Antonio Domenico; Ferracin, Manuela; Bonafè, Massimiliano; Lattanzio, Fabrizia; Olivieri, Fabiol

Uso di bioinchiostri a base di matrice extracellulare decellularizzata per la stampa 3D di sostituti del tessuto meniscale

Nonostante l’enorme potenziale degli approcci di ingegneria dei tessuti per la rigenerazione del tessuto meniscale, la realizzazione di una strategia terapeutica efficace a livello clinico rimane elusiva. Pertanto, solo impianti relativamente semplici per la riparazione del menisco hanno visto l’uso clinico. Sebbene questi approcci abbiano un grande potenziale nel campo della medicina rigenerativa, sono limitati all’uso di materiali con una bioattività relativamente scarsa, dalla difficoltà di progettare innesti anatomicamente accurati e dalle proprietà meccaniche relativamente insufficienti degli impianti rispetto al tessuto nativo, che possono limitare l’adozione clinica diffusa di queste tecniche. Nel seguente elaborato viene presentata la stampa 3D di equivalente del tessuto meniscale tramite bioink basati su dECM. Inizialmente, viene illustrato il funzionamento della 3D bioprinting e, con maggiore rilevanza, della 3D bioprinting per estrusione, oltre che la matrice extracellulare decellularizzata (dECM) come bioink per la stampa 3D. Successivamente, tramite l’analisi dell’articolo scientifico ‹‹3D printing of mechanically functional meniscal tissue equivalents using high concentration extracellular matrix inks›› pubblicato da Wang, B., et al. in Materials Today Bio 20 (2023) 100624 con DOI: 10.1016/j.mtbio.2023.100624, si presenta un caso specifico di un impianto meccanicamente funzionale per la riparazione del menisco, ottenuto stampando in 3D un inchiostro dECM ad alta concentrazione. Inoltre, sono stati analizzati e commentati l’importanza dei risultati ottenuti, con particolare attenzione alla valutazione reologica degli inchiostri dECM e sono state valutate la stampabilità 3D, le proprietà meccaniche e la biocompatibilità dei costrutti dECM. Infine, sono stati sottolineati i principali limiti di questi costrutti e valutati probabili sviluppi futuri

La checklist nei sistemi di valutazione costo efficacia

L’Health Technology Assessment (in breve, HTA) è, infatti, un approccio multidisciplinare per l’analisi delle implicazioni medico-cliniche, sociali, organizzative, economiche, etiche e legali di una tecnologia sanitaria, attraverso la valutazione di più dimensioni tra cui l’efficacia, la sicurezza clinica ed i costi. Questo lavoro si propone di verificare se le raccomandazioni e gli sforzi internazionali di garantire una certa qualità nella redazione delle analisi costo efficacia, attraverso l’utilizzo della checklist CHEERS, siano effettivamente rispettate o meno. Il lavoro è strutturato in due parti: in una prima sezione viene infatti descritto l’Health technology assessment come strumento innovativo per prendere le decisioni in sanità. Viene effettuato un excursus su come avviene lo studio, quali variabili vengono analizzate e quali sono le metodologie di indagine. In una seconda parte si è analizzato lo strumento della checklist come supporto alla redazione delle valutazioni di costo efficacia dei dispositivi medici. Viene descritto l’ obiettivo primario di questo strumento, ossia quello di creare delle procedure standardizzate nella stesura dei report al fine di implementare la trasparenza e la condivisibilità di informazioni per i decision maker sanitari. In ultima analisi, attraverso una review della letteratura effettuata su PubMed dei dispositivi medici per il monitoraggio del diabete, è stato individuato il peso della malattia per il sistema sanitario e quindi l’importanza delle decisioni allocative che riguardano questa patologia. È stata quindi eseguita una valutazione qualitativa delle pubblicazioni attualmente disponibili per valutare lo stadio di utilizzo della checklist a livello formale